Compare Cigna Corp (CI) vs Nvidia Corp (NVDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Nvidia Corp — how do they compare? Cigna Corp trades at $272.7 (market cap $73.56B), while Nvidia Corp trades at $216.68 (market cap $5.27T). The key difference: Nvidia Corp is far larger — about 71.6× Cigna Corp's market cap, and Cigna Corp pays the higher dividend (2.24%). Which is the better fit depends on your goals.
| CI | NVDA | |
|---|---|---|
Market Cap | $73.56B | $5.27T |
Sector | Health | Technology |
52-Week High | $311.00 | $235.75 |
52-Week Low | $244.41 | $165.17 |
Enterprise Value | $98.27B | $5.20T |
Dividend Yield | 2.24% | 0.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
NVIDIA (NVDA) trades at $217.16, down 3.04% on the day, amid a broader tech sell-off. The stock exhibits strong fundamentals with a 55.84% net income margin and has beaten earnings estimates for three consecutive quarters. Technical indicators show a bullish trend with support near $215, while analyst sentiment remains overwhelmingly positive with a consensus price target of $325.86. Recent news highlights AI-driven growth prospects but also cautions about valuation and market rotation.
The outlook for NVDA is bullish based on accelerating AI demand and robust financials, though risks include high valuation multiples and increased competition. Investment opportunity lies in sustained earnings growth and market leadership, but investors should be wary of volatility and geopolitical factors affecting tech stocks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →
